Prevalence and extent of glycemic excursions in well-controlled patients with type 2 diabetes mellitus using continuous glucose-monitoring system

Indian Journal of Medical Sciences

Volumn 63, Issue 2, 2009, Pages 66-71

  Bonakdaran, Shokoufeh ^a   Rajabian, Reza ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Continuous glucose monitoring system; Hyperglycemia; Hypoglycemia; Self monitoring blood glucose; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; MEGLITINIDE; METFORMIN; SULFONYLUREA;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; IRAN; MALE; MIDDLE AGED; MONITORING, AMBULATORY; MONITORING, PHYSIOLOGIC; PREVALENCE; RISK FACTORS; STATISTICS AS TOPIC;

EID: 64749084150     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.49237     Document Type: Article

References (21)

1. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-12.
2. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Teniil A, Goldstein DE. Defining the relationship between plasma glucose and HbA1C: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complication Trial. Diabetes Care 2002;25:275-8.
3. Kohnert KD, Augstein P, Heike P, Zander E, Peterson K, Freyse EJ, et al. Chronic hyperglycemia but not glucose variability determines HbA1C levels in well- controlled patients with type 2 diabetes. Diabetes Res Clin Pract 2007;77:420-6.
4. Boland E, Mansod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitation of Conventional methods of self monitoring of blood glucose. Diabetes Care 2001;24:1858-62.
5. Hirsch IB, Brownlee M. Should minimal blood glucose variability become gold standard of glycemic control? J Diabetes Compl 2005;19: 178-81.
6. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12.
7. Hay LC, Wilmshurst EG, Flucher G.Unrecognized hypo and hyperglycemia in well Controlled patients with type 2 diabetes mellitus. Diabetes Technol Ther 2003;5:19-26.
8. Ceriello A. The postprandial state and cardiovascular disease: Relevance to diabetes mellitus. Diabetes Metab Rev 2000;16:125-32.
9. Hanefeld M. Postprandial hyperglycemia: Noxious effects on the vessel wall. Int J Clin Prac 2002;129:45-50.
10. Ionescu-Tirgoviste C, Guja C, Ioacara S, Dumitrescu D, Tomescu I. Continuous Glucose monitoring: Physiologic and pathophysiologic significance. Rom J Intern Med 2004;42:381-93.
11. Rebrin K, Steil GM. Can interstitial glucose assessment replaces blood glucose measurement? Diabetes Technol Ther 2000;2:461-72.
12. Sachedina N, Pickup JC. Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects. Diabetes Med 2003;20:1012-5.
13. Cavalot F, Petrelli A, Travers M, Bonomo K, Fiora E, Conti M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particular in women. J Endocrinol Metab 2006;91:813-9.
14. Ceriello A, Cavarape A, Martinelli L, Da Ros R, Marra G, Quagliaro L, et al. The postprandial state in type 2 diabetes and endothelial dysfunction: Effects of insulin aspart. Diab Med 2004;21:171-5.
15. Bonora E. Postprandial peaks as a risk factor for cardiovascular disease: Epidemiological perspectives. Int J Clin Pract 2002;129:5-11.
16. Bode BW, Schwartz S, Stubbs HA, Block JE. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: Normative values. Diabetes Care 2005;28:2361-6.
17. The United Kingdom Prospective Diabetes Study group. Effect of intensive blood- glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 1998;352:854-65.
18. The United Kingdom Prospective Diabetes Study Research Group. Overview of 6 years of therapy type II diabetes: A progressive disease. Diabetes 1995;44:1249-58.
19. Mastrototaro J. The MiniMED Continuous Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab 1999;12:751-8.
20. Djakoure -Platonoff C, Radermercker R, Reach G, Slama G, Slama JI. Accuracy of the continuous glucose monitoring system in inpatient and outpatient condition. Diabetes Metab 2003;29:159-62.
21. Golicki DT, Golicka D, Groele L, Pankowska E. Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: A systemic review and meta- analysis. Diabetologia 2008;51:233-240.